𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetics of intravenous and oral isosorbide-5-mononitrate

✍ Scribed by U. Abshagen; G. Betzien; R. Endele; B. Kaufmann


Publisher
Springer
Year
1981
Tongue
English
Weight
589 KB
Volume
20
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Isosorbide 5-mononitrate pharmacokinetic
✍ T. Taylor; L. F. Chasseaud; R. Major; E. Doyle; A. Darragh πŸ“‚ Article πŸ“… 1981 πŸ› John Wiley and Sons 🌐 English βš– 428 KB πŸ‘ 2 views

## Abstract When isosorbide 5‐mononitrate was intravenously infused at a rate of 4 mg h ^βˆ’1^ for 2.5 h to five human subjects, its concentrations in plasma increased slowly to 185 ng ml^βˆ’1^ Β± 5 per cent C.V. at 2.5 h and a steady‐state plasma level was not reached during the infusion. When the infu

A combined single and multiple dose phar
✍ G. Storm; B. Oosterhuis; J. Bron; A. J. Wittebrood; A. P. De Jong; J. H. G. Jonk πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 596 KB

Pharmacokinetics of 20 mg isosorbide-5-mononitrate (IS-5-MN) after single and multiple administration of two different tablet formulations were investigated in twelve healthy human subjects using an open, randomized, two-way crossover experimental design. Pentacard@ 20 mg tablets were compared with

Investigation of a possible pharmacokine
✍ R. A. Lefebvre; G. Wilde; M. T. Rosseel; D. Duprez; J. Sutter; F. Pocchiari πŸ“‚ Article πŸ“… 1992 πŸ› Springer 🌐 English βš– 362 KB

The possibility of a pharmacokinetic interaction between isosorbide-5-mononitrate (5-ISMN) and epinine, the active metabolite of ibopamine, has been investigated in 8 healthy male subjects given single doses of 200 mg ibopamine and 20 mg 5-ISMN, separately and together. The plasma 5-ISMN concentrati